 The primary objective of the study is to determine the effects on attentional performance and motoric activity of 100 mg microencapsulated Glycine Bidicin from Biotiki compared to placebo after treatment with t.i.d. sublingual doses over 3 weeks each in children with low attentional performance and high motoric activity. 